Efficacy of probiotics for lowering of blood cholesterol

Efficacy of a combination of 2 protential probiotics stains for lowering of blood cholesterol

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20130000001

Enrollment

Registered

2013-01-27

Start date

2013-02-27

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypercholesterolemia cholesterol

Interventions

After enrollement&#44

subjects in this group will take a capsule of probiotics contained of Lactobacillus acidophilus 1&#44

000&#44

000 CFU and Bifidobacterium bifidum 1&#44

000 CFU three times a day for 6 weeks. ,After enrollement&#44

subjects in this group will take a capsule of placebo&#44

which indentical to a probiotics capsule&#44

three times a day for 6 weeks.

Active Comparator Drug,Placebo Comparator Drug

Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum),Placebo

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: serum cholesterol >200 mg/dL

Exclusion criteria

Exclusion criteria: 1. Presentation of any physical disability 2. Take any lipid lowering agents

Design outcomes

Primary

Measure	Time frame
reducution of cholesterol levels 6 weeks serum cholesterol levels	—

Secondary

Measure	Time frame
other serum lipid levels 6 weeks serum triglycerids, LDL and HDL cholesterol levels	—

Countries

Thailand

Contacts

Public ContactSanguansak Rerksuppaphol

SWU

sanguansak_r@hotmail.com0817231766

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026